Pyrazinamide plasma concentrations in young children with tuberculosis

Pediatr Infect Dis J. 2011 Mar;30(3):262-5. doi: 10.1097/inf.0b013e3181fbefe1.

Abstract

Pyrazinamide plasma concentrations were determined in 34 children (median age, 3.32 years) 1 month after commencing antituberculosis treatment. The median (interquartile range) peak concentration was 30.7 (25.5, 35.0) mg/L after a median dose of 23 mg/kg. Peak concentrations < 20 mg/L were found in 5 children (15%) and such low concentrations were particularly likely after doses < 20 mg/kg.

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / blood
  • Antitubercular Agents / pharmacokinetics*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Plasma / chemistry*
  • Pyrazinamide / administration & dosage*
  • Pyrazinamide / blood
  • Pyrazinamide / pharmacokinetics*
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Pyrazinamide